Optimi Health Corp. OPTH
—
4.82
(0.08)
(1.63%)
as of 25 Sep
- Market cap
- $28.1M
- P/E
- —
Follow OPTH
| Sep '25 | Sep '24 | Dec '23 | |
|---|---|---|---|
P/S ratio |
0.00 | 0.00 | 0.00 |
P/FCF ratio |
0.00 | 0.00 | 0.00 |
P/Operating CF |
(78.19) | (78.19) | (78.19) |
P/B ratio |
7.59 | 7.59 | 7.59 |
Price to Tangible BV |
7.59 | 7.59 | 7.59 |
EV/Sales |
0.00 | 0.00 | 0.00 |
EV/EBITDA |
0.00 | 0.00 | 0.00 |
EV/Operating CF |
(4.65) | (4.65) | (4.65) |
EV/FCF |
(4.52) | (4.52) | (4.52) |
Quick Ratio |
0.15 | 0.07 | 0.07 |
Current Ratio |
0.22 | 0.38 | 0.38 |
Net Debt/EBITDA |
(0.67) | 0.02 | 0.02 |
Debt/Assets |
23.72% | 0.00% | 0.00% |
Debt/Equity |
0.55 | 0.00 | 0.00 |
Asset Turnover |
0.03 | 0.03 | 0.00 |
Operating CF/Net income |
0.71 | 0.71 | 0.00 |
Capex/Depreciation |
(0.09) | (0.18) | — |
Interest Coverage |
0.00 | 0.00 | 0.00 |
| (45.23%) | 86.01% | 0.00% | |
| (24.61%) | (41.48%) | 0.00% | |
ROIC |
(35.59%) | (36.21%) | (32.42%) |
Return on Tangible Assets |
(64.86%) | (53.44%) | (53.44%) |
Average Days of Receivables |
81.43 | 116.19 | 116.19 |
Research and Development Expense of Revenue |
81.56% | 37.07% | 0.00% |
Selling, General and Administrative Expense of Revenue |
274.97% | 498.50% | 1,107.26% |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 |
Share Based Compensation of Revenue |
10.89% | 15.43% | 0.00% |
Graham Net Nets |
(0.35) | (0.35) | (0.35) |
Graham Number |
0.00 | 0.00 | 0.00 |
Free Cash Flow Yield |
(24.99%) | (24.99%) | (24.99%) |
Revenue per Share |
0.10 | 0.00 | 0.00 |
Operating CF per Share |
(0.59) | (0.04) | — |
Capex per Share |
(0.02) | 0.00 | — |
Free Cash Flow per Share |
(0.61) | (0.04) | — |
Cash per Share |
0.26 | 0.00 | 0.00 |
Shareholders Equity per Share |
1.47 | 0.08 | 0.00 |
Interest Debt per Share |
0.00 | 0.00 | — |
Book value per Share |
1.47 | 0.08 | 0.00 |
Free Cash Flow |
(1.94) | (3.26) | — |
Working Capital |
(4.76) | (1.46) | (1.46) |
Capital Expenditures |
(0.06) | (0.11) | — |
Net Current Asset Value |
(4.87) | (2.75) | (2.75) |
EV/EBIT |
0.00 | 0.00 | 0.00 |
Capex to Sales |
0.21 | 0.39 | 0.00 |
Net Profit Margin |
(870.64%) | (1,548.27%) | (1,548.27%) |
Price to Operating Income |
0.00 | 0.00 | 0.00 |
| Other line items | |||
Depreciation/Fixed assets |
0.08 | 0.07 | 0.00 |
Cash ROIC |
(132.53%) | (181.42%) | (137.19%) |
Accounts Receivable Turnover |
3.83 | 3.14 | 0.00 |
Accounts Payable Turnover |
0.42 | 0.00 | 0.00 |
Inventory Turnover |
0.80 | 0.13 | 0.00 |
Average Days of Payables |
1,026.75 | 2,831.05 | 0.00 |
Days of Inventory on Hand |
229.12 | 2,746.27 | 2,746.27 |
Average Receivables |
0.08 | 0.09 | — |
Average Payables |
0.84 | — | — |
Average Inventory |
0.44 | 0.66 | — |
Average Assets |
10.78 | 10.69 | — |
Average Common Equity |
5.87 | (5.16) | — |
Columns are period end dates